Zdrowie i gospodarka · 10/06/1998

FDA Publishes Guidance on Using Foreign Clinical Data with Ethnic Factors in Drug Registration

The FDA is releasing a new guidance document that outlines strategies for using clinical data from one region to support drug registrations in another, taking into account the impact of ethnic factors, in collaboration with the International Conference on Harmonisation (ICH)